Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06432868

Solarplast (R) Supplementation Effects Following High-intensity Resistance Exercise

Effects of Solarplast (R) Supplementation on Biomarkers of Muscle Damage, Inflammation and Recovery of Physical Performance Following High-intensity Resistance Exercise

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
46 (estimated)
Sponsor
Kent State University · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The primary goal of this investigation is to assess whether Solarplast (R) supplementation will improve recovery following heavy resistance exercise in active adults. The primary questions to be addressed are: Does Solarplast (R) decrease muscle damage and inflammation associated with heavy resistance exercise? Does Solarplast (R) reduce the decline in performance associate with heavy resistance exercise? Researchers will compare Solarplast (R) to a placebo (a look-alike substance that contains no active ingredients) to see if Solarplast (R) is effective at improving recovery. Participants will be asked to: Take Solarplast (R) or placebo daily for 4 weeks Visit the laboratory at least once per week to receive their supplement Report to the lab for 3 consecutive visits following supplementation to complete a heavy resistance training session and follow-up testing.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSolarplast (R)Daily supplementation for 28 days prior to heavy resistance exercise.
DIETARY_SUPPLEMENTPlaceboDaily supplementation for 28 days prior to heavy resistance exercise.

Timeline

Start date
2024-04-17
Primary completion
2025-03-31
Completion
2025-03-31
First posted
2024-05-29
Last updated
2024-05-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06432868. Inclusion in this directory is not an endorsement.